title: Fractional laser skin resurfacing.
abstract: Laser skin resurfacing (LSR) has evolved over the past 2 decades from traditional ablative to fractional nonablative and fractional ablative resurfacing. Traditional ablative LSR was highly effective in reducing rhytides, photoaging, and acne scarring but was associated with significant side effects and complications. In contrast, nonablative LSR was very safe but failed to deliver consistent clinical improvement. Fractional LSR has achieved the middle ground; it combined the efficacy of traditional LSR with the safety of nonablative modalities. The first fractional laser was a nonablative erbium-doped yttrium aluminum garnet (Er:YAG) laser that produced microscopic columns of thermal injury in the epidermis and upper dermis. Heralding an entirely new concept of laser energy delivery, it delivered the laser beam in microarrays. It resulted in microscopic columns of treated tissue and intervening areas of untreated skin, which yielded rapid reepithelialization. Fractional delivery was quickly applied to ablative wavelengths such as carbon dioxide, Er:YAG, and yttrium scandium gallium garnet (2,790 nm), providing more significant clinical outcomes. Adjustable laser parameters, including power, pitch, dwell time, and spot density, allowed for precise determination of percent surface area, affected penetration depth, and clinical recovery time and efficacy. Fractional LSR has been a significant advance to the laser field, striking the balance between safety and efficacy.
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. dralexiades@nyderm.org
authors.forename: Macrene R
authors.initials: MR
authors.lastname: Alexiades-Armenakas
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Dover
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Arndt
mesh_terms: D002921:Cicatrix / Q000601:surgery; D062109:Dermatologic Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D054020:Lasers, Gas / Q000009:adverse effects / Q000627:therapeutic use; D053844:Lasers, Solid-State / Q000009:adverse effects / Q000627:therapeutic use; D012060:Rejuvenation; D012867:Skin / Q000378:metabolism; D015595:Skin Aging